FDA批準首個生物仿製藥Zarxio（諾華公司）用於化療後升白細胞的藥物

FDA批準諾華旗下山多士（Sandoz）公司生產的首個生物仿製藥Zarxio（廉價版，歐洲商品名：Zarzio，was approved in Europe in 2009 as Zarzio）上市。用於治療原研藥Neupogen（Amgen，安進公司）批準的所有五個適應症。

http://mobile.nytimes.com/2015/03/07/health/fda-approves-zarxio-first-biosimilar-drug.html?referrer=

Biosimilar drugs, which could replace some costly remedies, being made at a Novartis plant.

A lower-cost version of the Amgen biologic drug Neupogen, used in cancer treatment,
could open the door to more such biosimilar medicines. 

所有跟帖： 

• 讚！ -夏日怡心- ♀ (0 bytes) () 03/07/2015 postreply 01:23:37